MiMedx Group (MDXG) Reports Q4 EPS of 12c, Offers Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/31/2026

1. INTC
2. AMZN
3. RDDT
4. COIN
5. PINS
6. FSLR
7. SYK
8. DASH
9. GILD
10. SBUX

Go back to MiMedx Group (MDXG) Reports Q4 EPS of 12c, Offers Guidance

MiMedx Announces 2015 Record Results

February 23, 2016 7:30 AM EST

MARIETTA, Ga., Feb. 23, 2016 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic membrane and other birth tissues, human skin and bone, and patent-protected processes and proprietary platforms to develop and market advanced products and therapies, announced today its record results for the full year and fourth quarter ended December 31, 2015.

Full Year 2015 Highlights are:

4th consecutive year of meeting or exceeding revenue guidance Revenue of $187.3 million increased by 58% over 2014 Revenue... More